Neither the WHO nor ICC classification schema recognize HGBL with MYC, BCL2, BCL6, and CCND1 rearrangements (a so-called quadruple hit) as a unique entity. This evidence concerns the gene BCL2 and intrahepatic cholangiocarcinoma.